Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 13/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 11/20 | 0.57 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.57 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.56 |
| ▸ | HTR2B | P41595 | 13/20 | 0.56 |
| ▸ | HTR2C | P28335 | 10/20 | 0.56 |
| ▸ | TMIGD3 | P0DMS9 | 5/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.51 |
| ▸ | HTR1D | P28221 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573781 | 0.86 | HTR2B (0.73) | ADORA1ADORA3ADORA2AHTR2BHTR2C | |
| SCHEMBL29573875 | 0.84 | HRH2 (0.53) | ADORA1ADORA3ADORA2AHSP90B1HTR2B | |
| SCHEMBL29573308 | 0.80 | ADORA3 (0.78) | ADORA1ADORA3ADORA2AHTR2BHTR2C | |
| SCHEMBL29573470 | 0.79 | ADORA3 (0.62) | ADORA1ADORA3ADORA2AHSP90B1HTR2B | |
| SCHEMBL29574455 | 0.79 | ADORA3 (0.55) | ADORA1ADORA3ADORA2AHTR2BHTR2C | |
| SCHEMBL29574073 | 0.78 | HTR2B (0.51) | ADORA1ADORA3ADORA2AHTR2BHTR2C | |
| SCHEMBL19464934 | 0.72 | HTR2B (1.00) | ADORA1ADORA3ADORA2AHSP90B1HTR2B | |
| SCHEMBL19464941 | 0.72 | HTR2B (1.00) | ADORA1ADORA3ADORA2AHSP90B1HTR2B | |
| SCHEMBL19464867 | 0.72 | HTR2B (1.00) | ADORA1ADORA3ADORA2AHSP90B1HTR2B | |
| SCHEMBL13276340 | 0.70 | ADORA3 (0.78) | ADORA1ADORA3ADORA2AHSP90B1HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116457356-A | A3 adenosine receptor agonists for use in medicine | 生物干预公司 | 2023-07-18 | — | — | CN | disclosed |
| EP-4196219-A1 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE | Biointervene, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022040241-A1 | A3 ADENOSINE RECEPTOR AGONISTS FOR USE IN MEDICINE | BIOINTERVENE, INC. (US) | 2022-02-24 | — | — | WO | disclosed |